title: Balancing the risks and benefits of prophylaxis: a reply to "Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions".
authors.affiliation: Department of Dermatology, University of California Irvine, Irvine, CA, USA.
authors.forename: Kyle T
authors.initials: KT
authors.lastname: Amber
mesh_terms: D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis; D018570:Risk Assessment
chemical_list: D007166:Immunosuppressive Agents